Does an extremely high dose of losartan afford superior renoprotection in the remnant model?
The renal protection afforded by ARB in NX is dose dependent. Maximal protection may require doses several fold higher than those currently employed.
Management of BP varies considerably and there appears to be little adherence to recommended guidelines. Targets are achieved more rapidly if a BP treatment protocol is utilized.